ArticleVascular health and risk management2021

The Anti-Cancer Effect of Pitavastatin May Be a Drug-Specific Effect: Subgroup Analysis of the TOHO-LIP Study.

Daiji Nagayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.